Syndecans as receptors for pericellular molecules

Extracellular Matrix: Pathobiology and Signaling

Volumn , Issue , 2012, Pages 467-483

  Xian, Xiaojie ^a   Whiteford, James R ^b   Couchman, John R ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84957844083     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (93)

1. Alexopoulou, A. N., Multhaupt, H. A., and Couchman, J. R. (2007). Syndecans in wound healing, inflammation and vascular biology. Int J Biochem Cell Biol 39, 505-528.
2. Andrae, J., Gallini, R., and Betsholtz, C. (2008). Role of platelet-derived growth factors in physiology and medicine. Genes Dev 22, 1276-1312.
3. Asada, M., Shinomiya, M., Suzuki, M., et al. (2009). Glycosaminoglycan affinity of the complete fibroblast growth factor family. Biochim Biophys Acta 1790, 40-48.
4. Bachy, S., Letourneur, F., and Rousselle, P. (2008). Syndecan-1 interaction with the LG4/5 domain in laminin-332 is essential for keratinocyte migration. J Cell Physiol 214, 238-249.
5. Bartlett, A. H., and Park, P. W. (2010). Proteoglycans in host-pathogen interactions: molecular mechanisms and therapeutic implications. Expert Rev Mol Med 12, e5.
6. Bass, M. D., Morgan, M. R., Roach, K. A., Settleman, J., Goryachev, A. B., and Humphries, M. J. (2008). p190RhoGAP is the convergence point of adhesion signals from alpha 5 beta 1 integrin and syndecan-4. J Cell Biol 181, 1013-1026.
7. Bax, D. V., Bernard, S. E., Lomas, A., et al. (2003). Cell adhesion to fibrillin-1 molecules and microfibrils is mediated by alpha 5 beta 1 and alpha v beta 3 integrins. J Biol Chem 278, 34605-34616.
8. Bax, D. V., Mahalingam, Y., Cain, S., et al. (2007). Cell adhesion to fibrillin-1: identification of an Arg-Gly-Asp-dependent synergy region and a heparin-binding site that regulates focal adhesion formation. J Cell Sci 120, 1383-1392.
9. Beachy, P. A., Hymowitz, S. G., Lazarus, R. A., Leahy, D. J., and Siebold, C. (2010). Interactions between Hedgehog proteins and their binding partners come into view. Genes Dev 24, 2001-2012.
10. Beauvais, D. M., Burbach, B. J., and Rapraeger, A. C. (2004). The syndecan-1 ectodomain regulates alphavbeta3 integrin activity in human mammary carcinoma cells. J Cell Biol 167, 171-181.
11. Beauvais, D. M., Ell, B. J., McWhorter, A. R., and Rapraeger, A. C. (2009). Syndecan-1 regulates alphavbeta3 and alphavbeta5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor. J Exp Med 206, 691-705.
12. Beauvais, D. M., and Rapraeger, A. C. (2010). Syndecan-1 couples the insulin-like growth factor-1 receptor to inside-out integrin activation. J Cell Sci 123, 3796-3807.
13. Cain, S. A., Baldock, C., Gallagher, J., et al. (2005). Fibrillin-1 interactions with heparin. Implications for microfibril and elastic fiber assembly. J Biol Chem 280, 30526-30537.
14. Cain, S. A., Baldwin, A. K., Mahalingam, Y., et al. (2008). Heparan sulfate regulates fibrillin-1 N- and C-terminal interactions. J Biol Chem 283, 27017-27027.
15. Chakravarti, R., Sapountzi, V., and Adams, J. C. (2005). Functional role of syndecan-1 cytoplasmic V region in lamellipodial spreading, actin bundling, and cell migration. Mol Biol Cell 16, 3678-3691.
16. Charo, I. F., Nannizzi, L., Smith, J. W., and Cheresh, D. A. (1990). The vitronectin receptor alpha v beta 3 binds fibronectin and acts in concert with alpha 5 beta 1 in promoting cellular attachment and spreading on fibronectin. J Cell Biol 1 11, 2795-2800.
17. Chen, E., Hermanson, S., and Ekker, S. C. (2004a). Syndecan-2 is essential for angiogenic sprouting during zebrafish development. Blood 103, 1710-1719.
18. Chen, L., Klass, C., and Woods, A. (2004b). Syndecan-2 regulates transforming growth factor-beta signaling. J Biol Chem 279, 15715-15718.
19. Chiquet-Ehrismann, R. (2004). Tenascins. Int J Biochem Cell Biol 36, 986-990.
20. Chiquet-Ehrismann, R., and Chiquet, M. (2003). Tenascins: regulation and putative functions during pathological stress. J Pathol 200, 488-499.
21. Clasper, S., Vekemans, S., Fiore, M., et al. (1999). Inducible expression of the cell surface heparan sulfate proteoglycan syndecan-2 (fibroglycan) on human activated macrophages can regulate fibroblast growth factor action. J Biol Chem 274, 24113-24123.
22. Cool, S. M., and Nurcombe, V. (2006). Heparan sulfate regulation of progenitor cell fate. J Cell Biochem 99, 1040-1051.
23. Couchman, J. R. (2003). Syndecans: proteoglycan regulators of cell-surface microdomains? Nat Rev Mol Cell Biol 4, 926-937.
24. Couchman, J. R. (2010). Transmembrane signaling proteoglycans. Annu Rev Cell Dev Biol 26, 89-114.
25. Dealy, C. N., Seghatoleslami, M. R., Ferrari, D., and Kosher, R. A. (1997). FGF-stimulated outgrowth and proliferation of limb mesoderm is dependent on syndecan-3. Dev Biol 184, 343-350.
26. Dedkov, E. I., Thomas, M. T., Sonka, M., et al. (2007). Synectin/syndecan-4 regulate coronary arteriolar growth during development. Dev Dyn 236, 2004-2010.
27. Esko, J. D., and Selleck, S. B. (2002). Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu Rev Biochem 71, 435-471.
28. Feyzi, E., Lustig, F., Fager, G., Spillmann, D., Lindahl, U., and Salmivirta, M. (1997). Characterization of heparin and heparan sulfate domains binding to the long splice variant of platelet-derived growth factor A chain. J Biol Chem 272, 5518-5524.
29. Fisher, M. C., Li, Y., Seghatoleslami, M. R., Dealy, C. N., and Kosher, R. A. (2006). Heparan sulfate proteoglycans including syndecan-3 modulate BMP activity during limb cartilage differentiation. Matrix Biol 25, 27-39.
30. Fukai, N., Kenagy, R. D., Chen, L., Gao, L., Daum, G., and Clowes, A. W. (2009). Syndecan-1: an inhibitor of arterial smooth muscle cell growth and intimal hyperplasia. Arterioscler Thromb Vasc Biol 29, 1356-1362.
31. Goodger, S. J., Robinson, C. J., Murphy, K. J., et al. (2008). Evidence that heparin saccharides promote FGF2 mitogenesis through two distinct mechanisms. J Biol Chem 283, 13001-13008.
32. Gopal, S., Bober, A., Whiteford, J. R., Multhaupt, H. A., Yoneda, A., and Couchman, J. R. (2010). Heparan sulfate chain valency controls syndecan-4 function in cell adhesion. J Biol Chem 285, 14247-14258.
33. Gotte, M. (2003). Syndecans in inflammation. FASEB J 17, 575-591.
34. Gotte, M., Bernfield, M., and Joussen, A. M. (2005). Increased leukocyte-endothelial interactions in syndecan-1-deficient mice involve heparan sulfate-dependent and -independent steps. Curr Eye Res 30, 417-422.
35. Gotte, M., Joussen, A. M., Klein, C., et al. (2002). Role of syndecan-1 in leukocyte-endothelial interactions in the ocular vasculature. Invest Ophthalmol Vis Sci 43, 1135-1141.
36. Grunewald, F. S., Prota, A. E., Giese, A., and Ballmer-Hofer, K. (2010). Structure-function analysis of VEGF receptor activation and the role of coreceptors in angiogenic signaling. Biochim Biophys Acta 1804, 567-580.
37. Hacker, U., Nybakken, K., and Perrimon, N. (2005). Heparan sulphate proteoglycans: the sweet side of development. Nat Rev Mol Cell Biol 6, 530-541.
38. Harmer, N. J., Ilag, L. L., Mulloy, B., Pellegrini, L., Robinson, C. V., and Blundell, T. L. (2004). Towards a resolution of the stoichiometry of the fibroblast growth factor (FGF)-FGF receptorheparin complex. J Mol Biol 339, 821-834.
39. Hayashida, K., Parks, W. C., and Park, P. W. (2009). Syndecan-1 shedding facilitates the resolution of neutrophilic inflammation by removing sequestered CXC chemokines. Blood 114, 3033-3043.
40. Horowitz, A., Tkachenko, E., and Simons, M. (2002). Fibroblast growth factor-specific modulation of cellular response by syndecan-4. J Cell Biol 157, 715-725.
41. Isenberg, J. S., Frazier, W. A., and Roberts, D. D. (2008). Thrombospondin-1: a physiological regulator of nitric oxide signaling. Cell Mol Life Sci 65, 728-742.
42. Iwabuchi, T., and Goetinck, P. F. (2006). Syndecan-4 dependent FGF stimulation of mouse vibrissae growth. Mech Dev 123, 831-841.
43. Kazerounian, S., Yee, K. O., and Lawler, J. (2008). Thrombospondins in cancer. Cell Mol Life Sci 65, 700-712.
44. Kielty, C. M., Sherratt, M. J., Marson, A., and Baldock, C. (2005). Fibrillin microfibrils. Adv Protein Chem 70, 405-436.
45. Kim, J., Lee, J. H., Park, H. S., et al. (2008). Syndecan-4 regulates platelet-derived growth factor-mediated MAP kinase activation by altering intracellular reactive oxygen species. FEBS Lett 582, 2725-2730.
46. Kirsch, T., Koyama, E., Liu, M., Golub, E. E., and Pacifici, M. (2002). Syndecan-3 is a selective regulator of chondrocyte proliferation. J Biol Chem 277, 42171-42177.
47. Klass, C. M., Couchman, J. R., and Woods, A. (2000). Control of extracellular matrix assembly by syndecan-2 proteoglycan. J Cell Sci 113, 493-506.
48. Kreuger, J., Spillmann, D., Li, J. P., and Lindahl, U. (2006). Interactions between heparan sulfate and proteins: the concept of specificity. J Cell Biol 174, 323-327.
49. Kuriyama, S., and Mayor, R. (2009). A role for syndecan-4 in neural induction involving ERK- and PKC-dependent pathways. Development 136, 575-584.
50. Lander, A. D. (1994). Targeting the glycosaminoglycan-binding sites on proteins. Chem Biol 1, 73-78.
51. Larrain, J., Carey, D. J., and Brandan, E. (1998). Syndecan-1 expression inhibits myoblast differentiation through a basic fibroblast growth factor-dependent mechanism. J Biol Chem 273, 32288-32296.
52. Li, Q., Park, P. W., Wilson, C. L., and Parks, W. C. (2002). Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury. Cell 111, 635-646.
53. Mahalingam, Y., Gallagher, J. T., and Couchman, J. R. (2007). Cellular adhesion responses to the heparin-binding (HepII) domain of fibronectin require heparan sulfate with specific properties. J Biol Chem 282, 3221-3230.
54. Manon-Jensen, T., Itoh, Y., and Couchman, J. R. (2010). Proteoglycans in health and disease: the multiple roles of syndecan shedding. FEBS J 277, 3876-3889.
55. Massague, J., Andres, J., Attisano, L., et al. (1992). TGF-beta receptors. Mol Reprod Dev 32, 99-104.
56. Matthews, H. K., Marchant, L., Carmona-Fontaine, C., et al. (2008). Directional migration of neural crest cells in vivo is regulated by syndecan-4/Rac1 and non-canonical Wnt signaling/RhoA. Development 135, 1771-1780.
57. McFall, A. J., and Rapraeger, A. C. (1998). Characterization of the high affinity cell-binding domain in the cell surface proteoglycan syndecan-4. J Biol Chem 273, 28270-28276.
58. Midwood, K. S., and Orend, G. (2009). The role of tenascin-C in tissue injury and tumorigenesis. J Cell Commun Signal 3, 287-310.
59. Midwood, K. S., Valenick, L. V., Hsia, H. C., and Schwarzbauer, J. E. (2004). Coregulation of fibronectin signaling and matrix contraction by tenascin-C and syndecan-4. Mol Biol Cell 15, 5670-5677.
60. Munoz, R., Moreno, M., Oliva, C., Orbenes, C., and Larrain, J. (2006). Syndecan-4 regulates non-canonical Wnt signalling and is essential for convergent and extension movements in Xenopus embryos. Nat Cell Biol 8, 492-500.
61. Murakami, M., Elfenbein A., and Simons M. (2008). Non-canonical fibroblast growth factor signalling in angiogenesis. Cardiovasc Res 78, 223-231.
62. Naimy, H., Buczek-Thomas, J. A., Nugent, M. A., Leymarie, N., and Zaia, J. (2011). Highly sulfated nonreducing end-derived heparan sulfate domains bind fibroblast growth factor-2 with high affinity and are enriched in biologically active fractions. J Biol Chem 286, 19311-19319.
63. Nunes, S. S., Outeiro-Bernstein, M. A., Juliano, L., et al. (2008). Syndecan-4 contributes to endothelial tubulogenesis through interactions with two motifs inside the pro-angiogenic N-terminal domain of thrombospondin-1. J Cell Physiol 214, 828-837.
64. Ogawa, T., Tsubota, Y., Hashimoto, J., Kariya, Y., and Miyazaki, K. (2007). The short arm of laminin gamma2 chain of laminin-5 (laminin-332) binds syndecan-1 and regulates cellular adhesion and migration by suppressing phosphorylation of integrin beta4 chain. Mol Biol Cell 18, 1621-1633.
65. Ohkawara, B., Iemura, S., ten Dijke, P., and Ueno, N. (2002). Action range of BMP is defined by its N-terminal basic amino acid core. Curr Biol 12, 205-209.
66. Okina, E., Manon-Jensen, T., Whiteford, J. R., and Couchman, J. R. (2009). Syndecan proteoglycan contributions to cytoskeletal organization and contractility. Scand J Med Sci Sports 19, 479-489.
67. Olivares, G. H., Carrasco, H., Aroca, F., Carvallo, L., Segovia, F., and Larrain, J. (2009). Syndecan-1 regulates BMP signaling and dorso-ventral patterning of the ectoderm during early Xenopus development. Dev Biol 329, 338-349.
68. Orend, G., and Chiquet-Ehrismann, R. (2006). Tenascin-C induced signaling in cancer. Cancer Lett 244, 143-163.
69. Orend, G., Huang, W., Olayioye, M. A., Hynes, N. E., and Chiquet-Ehrismann, R. (2003). Tenascin-C blocks cell-cycle progression of anchorage-dependent fibroblasts on fibronectin through inhibition of syndecan-4. Oncogene 22, 3917-3926.
70. Pellegrini, L., Burke, D. F., von Delft, F., Mulloy, B., and Blundell, T. L. (2000). Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin. Nature 407, 1029-1034.
71. Robinson, C. J., Harmer, N. J., Goodger, S. J., Blundell, T. L., and Gallagher, J. T. (2005). Cooperative dimerization of fibroblast growth factor 1 (FGF1) upon a single heparin saccharide may drive the formation of 2:2:1 FGF1.FGFR2c.heparin ternary complexes. J Biol Chem 280, 42274-42282.
72. Robinson, P. N., Arteaga-Solis, E., Baldock, C., et al. (2006). The molecular genetics of Marfan syndrome and related disorders. J Med Genet 43, 769-787.
73. Salmivirta, M., Elenius, K., Vainio, S., et al. (1991). Syndecan from embryonic tooth mesenchyme binds tenascin. J Biol Chem 266, 7733-7739.
74. Schlessinger, J., Plotnikov, A. N., Ibrahimi, O. A., et al. (2000). Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Mol Cell 6, 743-750.
75. St-Germain, J. R., Taylor, P., Tong, J., et al. (2009). Multiple myeloma phosphotyrosine proteomic profile associated with FGFR3 expression, ligand activation, and drug inhibition. Proc Natl Acad Sci U S A 106, 20127-20132.
76. Stanford, K. I., Bishop, J. R., Foley, E. M., et al. (2009). Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in mice. J Clin Invest 1 19, 3236-3245.
77. Sugawara, K., Tsuruta, D., Ishii, M., Jones, J. C., and Kobayashi, H. (2008). Laminin-332 and -511 in skin. Exp Dermatol 17, 473-480.
78. Sweeney, S. M., Orgel, J. P., Fertala, A., et al. (2008). Candidate cell and matrix interaction domains on the collagen fibril, the predominant protein of vertebrates. J Biol Chem 283, 21187-21197.
79. Taylor, K. R., and Gallo, R. L. (2006). Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation. FASEB J 20, 9-22.
80. Tkachenko, E., Elfenbein, A., Tirziu, D., and Simons, M. (2006). Syndecan-4 clustering induces cell migration in a PDZ-dependent manner. Circ Res 98, 1398-1404.
81. Veeman, M. T., Axelrod, J. D., and Moon, R. T. (2003). A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling. Dev Cell 5, 367-377.
82. Viklund, L., Vorontsova, N., Henttinen, T., and Salmivirta, M. (2006). Syndecan-1 regulates FGF8b responses in S115 mammary carcinoma cells. Growth Factors 24, 151-157.
83. Volk, R., Schwartz, J. J., Li, J., Rosenberg, R. D., and Simons, M. (1999). The role of syndecan cytoplasmic domain in basic fibroblast growth factor-dependent signal transduction. J Biol Chem 274, 24417-24424.
84. Vuoriluoto, K., Jokinen, J., Kallio, K., Salmivirta, M., Heino, J., and Ivaska, J. (2008). Syndecan-1 supports integrin alpha2beta1-mediated adhesion to collagen. Exp Cell Res 314, 3369-3381.
85. Whiteford, J. R., Behrends, V., Kirby, H., Kusche-Gullberg, M., Muramatsu, T., and Couch-man, J. R. (2007). Syndecans promote integrin-mediated adhesion of mesenchymal cells in two distinct pathways. Exp Cell Res 313, 3902-3913.
86. Whiteford, J. R., Xian, X., Chaussade, C., Vanhaesebroeck, B., Nourshargh, S., and Couch-man, J. R. (2011). Syndecan-2 is a novel ligand for the protein tyrosine phosphatase receptor CD148. Mol Biol Cell 22, 3609-3624.
87. Wilkins-Port, C. E., Sanderson, R. D., Tominna-Sebald, E., and McKeown-Longo, P. J. (2003). Vitronectin's basic domain is a syndecan ligand which functions in trans to regulate vitronectin turnover. Cell Commun Adhes 10, 85-103.
88. Williams, S. A., and Schwarzbauer, J. E. (2009). A shared mechanism of adhesion modulation for tenascin-C and fibulin-1. Mol Biol Cell 20, 1141-1149.
89. Wodarz, A., and Nusse, R. (1998). Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol 14, 59-88.
90. Xian, X., Gopal, S., and Couchman, J. R. (2010). Syndecans as receptors and organizers of the extracellular matrix. Cell Tissue Res 339, 31-46.
91. Yamashita, H., Goto, A., Kadowaki, T., and Kitagawa, Y. (2004). Mammalian and Drosophila cells adhere to the laminin alpha4 LG4 domain through syndecans, but not glypicans. Biochem J 382, 933-943.
92. Zafiropoulos, A., Fthenou, E., Chatzinikolaou, G., and Tzanakakis, G. N. (2008). Glycosaminoglycans and PDGF signaling in mesenchymal cells. Connect Tissue Res 49, 153-156.
93. Zhang, Y., Li, J., Partovian, C., Sellke, F. W., and Simons, M. (2003). Syndecan-4 modulates basic fibroblast growth factor 2 signaling in vivo. Am J Physiol Heart Circ Physiol 284, H2078-H2082.